- Your cart is empty
- Continue Shopping
Sybrava 284mg Injection
Uses of Sybrava 284mg Injection
- Combination to other statin therapy and diet for treating primary hyperlipidemia [heterozygous familial hypercholesterolemia ]
Product Description
Introduction to Sybrava 284mg Injection
Sybrava 284 mg Injection is a medicine containing Inclisiran as an active ingredient which belongs to the class of medications called proprotein convertase subtilisin kexin type-9 [PCSK-9]. It is first in class and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol. It is used to lower the level of low density lipoprotein. It is prescribed as a complement to statin medication and diet in the management of patients with primary high cholesterol levels.
It is not recommended to use this medication if you are allergic to the active compound Sybrava 284 mg Injection or its components. It is not recommended to use during pregnancy and breastfeeding, it is advised to consult your physician regarding further queries. It is not recommended for children and adolescents under the age of 18. You should be taking a statin and following a diet to reduce your cholesterol before beginning this therapy. For the duration that you are receiving Sybrava 284 mg Injection, you should continue taking the statin and adhering to this cholesterol-lowering diet. Do not stop taking this medicine without consulting your doctor. Talk to your doctor if you have kidney disorders, breathing problems, liver disorders, heart problems, intolerance to sugars before taking this medicine. Inform your physician or pharmacist of any additional medications you are taking, have recently taken, or may take, including over-the-counter medications and herbal remedies.
Therapeutic Effects of Sybrava 284mg Injection
Sybrava 284 mg Injection is a small interfering RNA (siRNA) molecule that interferes with the production of PCSK9 protein in the liver. By inhibiting PCSK9 synthesis, Sybrava 284 mg Injection increases the number of LDL receptors on liver cells, promoting the clearance of LDL cholesterol from the blood. This mechanism ultimately leads to lower LDL cholesterol levels in the bloodstream, helping to reduce the risk of cardiovascular events such as heart attack and stroke.
Interaction of Sybrava 284mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Sybrava 284 mg Injection and reduce effectiveness by causing undesirable side effects.
More Information about Sybrava 284mg Injection
- Sybrava 284 mg Injection should be stored at room temperature, between 20°C to 25°C (68°F to 77°F).
- Protected from light.
- Keep it in its original packaging until it is ready to be used.
- Keep out of the reach of children and pets.
- Should be disposed of properly.
How to consume Sybrava 284mg Injection
Sybrava 284 mg Injection will be administered to you by a healthcare professional in a hospital setting. It is usually administered as a subcutaneous injection into the abdomen, upper arm, or thigh. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors. The second dose is given after 3 months and the subsequent dose every 6 months.
Safety Advices for Sybrava 284mg Injection
Pregnancy
It is recommended to avoid this medication during pregnancy as Sybrava 284 mg Injection is unsafe during pregnancy as it can cause fetal harm. It is advised to inform your physician if you are pregnant or think you may be pregnant before starting the treatment.
Breast Feeding
It is unknown whether afatinib dimaleate is excreted in human milk. It is advised to consult your doctor before taking Sybrava 284 mg Injection. Your doctor may prescribe this if the benefits of the drug outweighs the risks involved.
Lungs
It is unknown whether Sybrava 284 mg Injection Injection is safe for patients with lung problems. Consult your doctor if you have lung disease before starting the treatment.
Liver
Sybrava 284 mg Injection is primarily metabolized in the liver, so inform your healthcare provider if you have any liver problems or diseases.
Alcohol
It is unknown if consuming alcoholic beverages while taking Sybrava 284 mg Injection injection is safe. Please consult with your physician.
Driving
It is safe to travel, drive a car, or operate heavy machinery after receiving Enoxaparin Injection. The drug does not impair alertness or coordination.
Side Effects of Sybrava 284mg Injection
Like all medications, Sybrava 284 mg Injection can cause side effects, although not everyone who takes it will experience them.
Common:
- Injection site reactions like redness, rash and pain
- Arthralgia
- Bronchitis
- Fever
- Chills
- Headache
Related products
Reviews
There are no reviews yet.